Status:
UNKNOWN
Home-based Cognitive Treatment and Cognitive Impairment
Lead Sponsor:
IRCCS National Neurological Institute "C. Mondino" Foundation
Conditions:
Cognitive Impairment
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
The prevalence of neurodegenerative diseases is expected to increase over the next years, in parallel with the aging of the world population. Therefore, it is important to identify new methods to prev...
Detailed Description
Non-pharmacological intervention may represent adjunctive therapy to medications in order to delay the onset of the cognitive deficits or dementia. Moreover, increasing evidence suggests that environm...
Eligibility Criteria
Inclusion
- presence of mild dementia, mild cognitive impairment; vascular cognitive impairment, subjective cognitive impairment;
- age between 50 and 85 years;
- educational level ≥ 5 years.
Exclusion
- MMSE \< 20
- CRD \> 1
- pre-existing cognitive impairment (e.g. aphasia, neglect);
- severe disturbances in consciousness;
- concomitant severe psychiatric disease or others neurological conditions (e.g. depression and behavioral disorders).
Key Trial Info
Start Date :
June 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04889560
Start Date
June 30 2021
End Date
June 30 2024
Last Update
February 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dementia Research Center
Pavia, Italy, 27100